Inhibition of piezo1 prevents chronic cerebral hypoperfusion-induced cognitive impairment and blood brain barrier disruption
Neurochemistry International · 2024-05 · 175 · 105702
DOI: 10.1016/j.neuint.2024.105702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2024-05. Verfasst von Fei Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Vascular Surgery, Jini…. Hauptthemen laut MEDLINE: Brain Ischemia, Cognitive Dysfunction. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Chronic cerebral hypoperfusion (CCH) plays a critical role in the onset and progression of vascular dementia (VD), which is now recognized as the second most common form of dementia after Alzheimer's disease (AD). The mechanosensitive piezo1 channel has been identified to play important roles in several neurological disorders. However, the roles and possible mechanisms of piezo1 in CCH-induced cognitive decline and blood brain barrier (BBB) disruption, as well as the underlying mechanisms remain elusive. In this study, the CCH model was established by bilateral common carotid artery occlusion in rats and by oxygen and glucose deprivation/reoxygenation (OGD/R) in bEnd.3 cells. The results demonstrated that the antagonist of piezo1 GsMTx4 ameliorated CCH-induced cognitive dysfunction and mitigated cerebral edema. Furthermore, this study indicated that GsMTx4 improved the permeability and integrity of BBB and protected cerebral microvasculature after CCH. In vitro, GsMTx4 improved cell viability, promoted the ability of cell motility and migration, and inhibited the degradation of BBB integrity-related proteins by inhibiting NLRP3 inflammasome activation. In addition, NLRP3 agonist abolished the beneficial effects of GsMTx4. Collectively, our results demonstrate that piezo1 might be involved in CCH-induced cognitive impairment and BBB damage, which may be at least partially mediated through regulation of NLRP3 inflammasome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Vascular Surgery, Jining NO.1 People's Hospital, Jining, 272000, China.
- Department of Physiology, Jining Medical University, Jining, 272000, China.
- Department of Vascular Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: hnxgwk@126.com.
Zitieren
APA
Xu, F., Xin, Q., Ren, M., Shi, P., & Wang, B. (2024). Inhibition of piezo1 prevents chronic cerebral hypoperfusion-induced cognitive impairment and blood brain barrier disruption. Neurochemistry International, 175, 105702. https://doi.org/10.1016/j.neuint.2024.105702
Vancouver
Xu F, Xin Q, Ren M, Shi P, Wang B. Inhibition of piezo1 prevents chronic cerebral hypoperfusion-induced cognitive impairment and blood brain barrier disruption. Neurochemistry International. 2024;175:105702. doi:10.1016/j.neuint.2024.105702
BibTeX
@article{Xu2024,
author = {Xu, Fei and Xin, Qing and Ren, Mengyao and Shi, Peixin and Wang, Bing},
title = {Inhibition of piezo1 prevents chronic cerebral hypoperfusion-induced cognitive impairment and blood brain barrier disruption},
journal = {Neurochemistry International},
year = {2024},
volume = {175},
pages = {105702},
doi = {10.1016/j.neuint.2024.105702}
}
EUVIMED